FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2068602287> ?p ?o ?g. }

• W2068602287 endingPage "S109" @default.
• W2068602287 startingPage "S104" @default.
• W2068602287 abstract "Osteoporosis (OP) and chronic kidney disease (CKD) both independently affect bone health. A significant number of patients with CKD have decreased bone mineral density (BMD), are at high risk of fragility fractures and have an increased morbidity and mortality risk. With an aging population, these observations are not only dependent on “renal osteodystrophy” but also on the associated OP. As BMD predicts incident fractures in CKD patients (part I), we now aim to analyze the potential therapeutic consequences. Post hoc analyses of randomized studies have shown that the efficacy of drugs such as alendronate, risedronate, raloxifene, teriparatide and denosumab is similar to that of the general population in patients with a mild/moderate decline in their glomerular filtration rate (especially CKD-3). These studies have some flaws however, as they included mostly “healthy” women with no known diagnosis of CKD and generally with normal lab test results. Nevertheless, there are also some positive preliminary data in more advanced stages (CKD-4), even though in CKD-5D they are more limited. Therefore, at least in the absence of significant mineral metabolism disorders (i.e. severe hyperparathyroidism), the potential benefit of these drugs should be considered in patients with a high or very high fracture risk. It is an important change that the new guidelines do not make it a requirement to first perform a bone biopsy and that the risk/benefit ratio of these drugs may be justified. However, we must also be aware that most studies are not consistent and the level of evidence is low. Consequently, any pharmacological intervention (risk/benefit) should be prudent and individualized.La osteoporosis (OP) y la enfermedad renal crónica (ERC) influyen independientemente en la salud ósea. Numerosos pacientes con ERC presentan una disminución de densidad mineral ósea (DMO), un elevado riesgo de fracturas por fragilidad ósea y un incremento de su morbimortalidad. Con el envejecimiento de la población estos hechos no son dependientes solo de la «osteodistrofia renal» sino también de la OP asociada. Dado que la DMO tiene capacidad predictiva en pacientes con ERC (parte I), ahora analizaremos las implicaciones terapéuticas derivadas. Análisis post hoc de estudios aleatorizados han mostrado que fármacos como alendronato, risedronato, raloxifeno, teriparatida o denosumab tienen una eficacia comparable a la población general en pacientes con una disminución leve-moderada del filtrado glomerular (especialmente ERC-3). Estos estudios tienen limitaciones, pues incluyen mayoritariamente mujeres «sanas», sin diagnóstico conocido de ERC y habitualmente con parámetros normales de laboratorio; sin embargo, también existen datos positivos preliminares en estadios más avanzados (ERC-4) y más limitados en ERC-5D. Por todo ello, al menos en ausencia de alteraciones significativas del metabolismo mineral (i.e., hiperparatiroidismo severo), el beneficio potencial de dichos fármacos debería ser considerado en pacientes que presenten un riesgo de fractura elevado o muy elevado. Es novedad importante que las nuevas guías no condicionan su uso a la práctica de una biopsia ósea previa y que el beneficio/riesgo de estos fármacos podría estar justificado. Sin embargo, debemos considerar que la mayoría de estudios no son consistentes y tienen un bajo grado de evidencia, por lo que la indicación farmacológica (riesgo/beneficio) debe ser individualizada y prudente." @default.
• W2068602287 created "2016-06-24" @default.
• W2068602287 creator A5023947803 @default.
• W2068602287 creator A5027188695 @default.
• W2068602287 creator A5055802480 @default.
• W2068602287 creator A5088877203 @default.
• W2068602287 date "2012-10-01" @default.
• W2068602287 modified "2023-09-25" @default.
• W2068602287 title "Osteoporosis: Chronic Kidney Disease in Rheumatology Practice" @default.
• W2068602287 cites W1971488797 @default.
• W2068602287 cites W1977246587 @default.
• W2068602287 cites W1978798478 @default.
• W2068602287 cites W2014026700 @default.
• W2068602287 cites W2048183034 @default.
• W2068602287 cites W2048268975 @default.
• W2068602287 cites W2055233141 @default.
• W2068602287 cites W2084636593 @default.
• W2068602287 cites W2085739273 @default.
• W2068602287 cites W2087280577 @default.
• W2068602287 cites W2088793027 @default.
• W2068602287 cites W2090820297 @default.
• W2068602287 cites W2099783744 @default.
• W2068602287 cites W2108529411 @default.
• W2068602287 cites W2116773713 @default.
• W2068602287 cites W2122995620 @default.
• W2068602287 cites W2149751845 @default.
• W2068602287 cites W2149775776 @default.
• W2068602287 cites W2151836782 @default.
• W2068602287 cites W2172159264 @default.
• W2068602287 cites W2409849247 @default.
• W2068602287 doi "https://doi.org/10.1016/s1297-319x(12)70017-9" @default.
• W2068602287 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23098842" @default.
• W2068602287 hasPublicationYear "2012" @default.
• W2068602287 type Work @default.
• W2068602287 sameAs 2068602287 @default.
• W2068602287 citedByCount "6" @default.
• W2068602287 countsByYear W20686022872015 @default.
• W2068602287 countsByYear W20686022872018 @default.
• W2068602287 countsByYear W20686022872019 @default.
• W2068602287 countsByYear W20686022872022 @default.
• W2068602287 crossrefType "journal-article" @default.
• W2068602287 hasAuthorship W2068602287A5023947803 @default.
• W2068602287 hasAuthorship W2068602287A5027188695 @default.
• W2068602287 hasAuthorship W2068602287A5055802480 @default.
• W2068602287 hasAuthorship W2068602287A5088877203 @default.
• W2068602287 hasConcept C121608353 @default.
• W2068602287 hasConcept C124490489 @default.
• W2068602287 hasConcept C126322002 @default.
• W2068602287 hasConcept C159641895 @default.
• W2068602287 hasConcept C170033053 @default.
• W2068602287 hasConcept C177713679 @default.
• W2068602287 hasConcept C2776286101 @default.
• W2068602287 hasConcept C2776541429 @default.
• W2068602287 hasConcept C2776699218 @default.
• W2068602287 hasConcept C2776886416 @default.
• W2068602287 hasConcept C2777308945 @default.
• W2068602287 hasConcept C2778653478 @default.
• W2068602287 hasConcept C2779889926 @default.
• W2068602287 hasConcept C2908647359 @default.
• W2068602287 hasConcept C530470458 @default.
• W2068602287 hasConcept C71924100 @default.
• W2068602287 hasConcept C84606932 @default.
• W2068602287 hasConcept C99454951 @default.
• W2068602287 hasConceptScore W2068602287C121608353 @default.
• W2068602287 hasConceptScore W2068602287C124490489 @default.
• W2068602287 hasConceptScore W2068602287C126322002 @default.
• W2068602287 hasConceptScore W2068602287C159641895 @default.
• W2068602287 hasConceptScore W2068602287C170033053 @default.
• W2068602287 hasConceptScore W2068602287C177713679 @default.
• W2068602287 hasConceptScore W2068602287C2776286101 @default.
• W2068602287 hasConceptScore W2068602287C2776541429 @default.
• W2068602287 hasConceptScore W2068602287C2776699218 @default.
• W2068602287 hasConceptScore W2068602287C2776886416 @default.
• W2068602287 hasConceptScore W2068602287C2777308945 @default.
• W2068602287 hasConceptScore W2068602287C2778653478 @default.
• W2068602287 hasConceptScore W2068602287C2779889926 @default.
• W2068602287 hasConceptScore W2068602287C2908647359 @default.
• W2068602287 hasConceptScore W2068602287C530470458 @default.
• W2068602287 hasConceptScore W2068602287C71924100 @default.
• W2068602287 hasConceptScore W2068602287C84606932 @default.
• W2068602287 hasConceptScore W2068602287C99454951 @default.
• W2068602287 hasLocation W20686022871 @default.
• W2068602287 hasLocation W20686022872 @default.
• W2068602287 hasOpenAccess W2068602287 @default.
• W2068602287 hasPrimaryLocation W20686022871 @default.
• W2068602287 hasRelatedWork W1824311463 @default.
• W2068602287 hasRelatedWork W2413330320 @default.
• W2068602287 hasRelatedWork W2764266869 @default.
• W2068602287 hasRelatedWork W2769669874 @default.
• W2068602287 hasRelatedWork W2982670914 @default.
• W2068602287 hasRelatedWork W4226275014 @default.
• W2068602287 hasRelatedWork W4239467322 @default.
• W2068602287 hasRelatedWork W2186476187 @default.
• W2068602287 hasRelatedWork W4214779449 @default.
• W2068602287 hasRelatedWork W4221139041 @default.
• W2068602287 hasVolume "79" @default.
• W2068602287 isParatext "false" @default.
• W2068602287 isRetracted "false" @default.

• next